A Pilot and Feasibility Study of Continuous Cardiac Output and Blood Pressure Monitoring during Intermittent Hemodialysis
Blood Purification · 2024
DOI: 10.1159/000541201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Sofia Spano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia, sofia.spano@icloud.com. Hauptthemen laut MEDLINE: Renal Dialysis, Feasibility Studies, Cardiac Output.
Abstract (Originalsprache)
Introduction
Hypotension is common during intermittent hemodialysis (IHD) and may be due to a decreased cardiac index (CI). However, no study has simultaneously and continuously measured CI and mean arterial pressure (MAP) to understand the prevalence, severity, and duration of CI decreases or relate them to MAP, blood volume (BV) and net ultrafiltration (NUF) rate.
Methods
In a prospective, pilot and feasibility investigation, we studied 10 chronic IHD patients. We used the ClearSight System™ to continuously monitor CI and MAP; the CRIT-LINE®IV monitor to detect BV changes and collected data on NUF rate.
Results
Device tolerance and compliance was 100%. All patients experienced at least ≥ 1 episode of severe CI decrease (> 25% from baseline), with a median duration of 24 minutes [IQR 6-87] and of 68 minutes [14-106] for moderate decreases (>15% but 25% from baseline). Eight patients experienced a low CI state (<2.2 L/min/m2). The lowest CI was 0.9 L/min/m2 with a concomitant MAP of 94 mmHg. When the fall in CI was severe, MAP increased in 58% of cases and remained stable in 28%. Overall, CI decreased by -0.55 L/min/m2 when BV decrease was moderate vs mild (p<0.001) and by -0.8 L/min/m2 when NUF rate was high vs low (p<0.001).
Conclusion
Continuous CI monitoring is feasible in IHD and shows frequent moderate-severe CI decreases, sometimes to low CI state levels. Such decreases are typically associated with markers of decreased intravascular volume status but not with a decrease in MAP, implying marked vasoconstriction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia, sofia.spano@icloud.com.
- Department of Anesthesiology and Intensive Care Units, IRCCS Humanitas Research Hospital, Milan, Italy, sofia.spano@icloud.com.
- Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
- Department of Nephrology, Austin Hospital, Heidelberg, Victoria, Australia.
- Department of Nephrology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
- Department of Critical Care, School of Medicine, University of Melbourne, Parkville, Victoria, Australia.
Zitieren
APA
Spano, S., Maeda, A., Lam, J., Chaba, A., Phongphithakchai, A., Pattamin, N., Hikasa, Y., See, E., Mount, P., & Bellomo, R. (2024). A Pilot and Feasibility Study of Continuous Cardiac Output and Blood Pressure Monitoring during Intermittent Hemodialysis. Blood Purification. https://doi.org/10.1159/000541201
Vancouver
Spano S, Maeda A, Lam J, Chaba A, Phongphithakchai A, Pattamin N, et al. A Pilot and Feasibility Study of Continuous Cardiac Output and Blood Pressure Monitoring during Intermittent Hemodialysis. Blood Purification. 2024. doi:10.1159/000541201
BibTeX
@article{Spano2024,
author = {Spano, Sofia and Maeda, Akinori and Lam, Joey and Chaba, Anis and Phongphithakchai, Atthaphong and Pattamin, Nuttapol and Hikasa, Yukiko and See, Emily and Mount, Peter and Bellomo, Rinaldo},
title = {A Pilot and Feasibility Study of Continuous Cardiac Output and Blood Pressure Monitoring during Intermittent Hemodialysis},
journal = {Blood Purification},
year = {2024},
doi = {10.1159/000541201}
}
EUVIMED